IRIS
SORRENTINO, Dario Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.710
AS - Asia 4.140
EU - Europa 2.814
SA - Sud America 761
Continente sconosciuto - Info sul continente non disponibili 406
AF - Africa 86
OC - Oceania 3
Totale 19.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.527
SG - Singapore 2.075
CN - Cina 923
UA - Ucraina 783
BR - Brasile 591
DE - Germania 532
HK - Hong Kong 395
FI - Finlandia 350
VN - Vietnam 285
IT - Italia 251
SE - Svezia 190
RU - Federazione Russa 183
FR - Francia 169
IE - Irlanda 144
TR - Turchia 113
CA - Canada 98
IN - India 83
GB - Regno Unito 82
AR - Argentina 56
BD - Bangladesh 43
KR - Corea 37
NL - Olanda 34
EC - Ecuador 31
IQ - Iraq 26
MX - Messico 26
VE - Venezuela 25
ID - Indonesia 23
CO - Colombia 20
PL - Polonia 20
ZA - Sudafrica 18
CL - Cile 17
ES - Italia 16
IR - Iran 16
BE - Belgio 14
JP - Giappone 14
PK - Pakistan 13
TN - Tunisia 13
KE - Kenya 11
EU - Europa 10
JM - Giamaica 10
PY - Paraguay 10
SA - Arabia Saudita 10
MA - Marocco 9
AT - Austria 8
EG - Egitto 8
IL - Israele 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
JO - Giordania 7
NI - Nicaragua 6
NP - Nepal 6
PE - Perù 6
AL - Albania 5
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
UZ - Uzbekistan 5
BB - Barbados 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
PR - Porto Rico 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
MY - Malesia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
RO - Romania 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
CI - Costa d'Avorio 2
GE - Georgia 2
LB - Libano 2
LT - Lituania 2
MF - Saint Martin 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
Totale 19.500
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.394
Fairfield 1.207
Ashburn 943
Singapore 862
Houston 829
Ann Arbor 640
Seattle 507
Jacksonville 503
Chandler 497
Wilmington 469
Dearborn 418
Beijing 414
Cambridge 406
San Jose 396
Hong Kong 389
Council Bluffs 293
Munich 202
Boardman 200
Princeton 146
Dublin 143
Helsinki 129
Lauterbourg 129
Los Angeles 94
Izmir 87
Ho Chi Minh City 76
Hefei 72
San Diego 71
Buffalo 67
Dallas 65
Hanoi 61
Roanoke 61
Santa Clara 61
Udine 54
São Paulo 49
Des Moines 46
New York 43
The Dalles 43
Nanjing 39
Redondo Beach 39
Milan 38
Dong Ket 36
Seoul 35
Kunming 30
Ottawa 30
Norwalk 28
Ogden 28
Orem 27
Atlanta 26
Mumbai 25
Jinan 24
Rio de Janeiro 23
Guangzhou 20
North Bergen 19
Toronto 18
Warsaw 18
Curitiba 17
Miano 16
Nanchang 15
Phoenix 15
Redmond 15
Brooklyn 14
Chicago 14
Brasília 13
Campinas 13
Quito 13
Torre Del Greco 13
Turku 13
Andover 12
Belo Horizonte 12
Brussels 12
Falls Church 12
Haiphong 12
Montreal 12
Thái Bình 12
Tokyo 12
Dhaka 11
Grafing 11
Boston 10
Guayaquil 10
Washington 10
Frankfurt am Main 9
London 9
Redwood City 9
Rome 9
San Francisco 9
Charlotte 8
Chennai 8
Columbus 8
Da Nang 8
Fuzhou 8
Hải Dương 8
Johannesburg 8
Mexico City 8
Miami 8
Moscow 8
Nairobi 8
Newark 8
Nuremberg 8
Porto Alegre 8
Salvador 8
Totale 13.053
Salva come PNG Salva come JPEG
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 331
Mechanisms of cellular uptake of free fatty acids 272
Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities 248
Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out 234
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 210
Bringing Top-End Endoscopy to Regional Australia: Hurdles and Benefits 202
"Albumin Receptor" uptake kinetics do not require an intact lobular architecture and are not specific for albumin 197
Ustekinumab as induction and maintenance therapy for ulcerative colitis 194
Anti-TNF's for Postoperative Recurrence in Crohn's Disease: The If's and How's 193
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 188
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease 186
Infliximab in Crohn's disease: a look at the (not so distant) future. 184
Acute severe colitis: infliximab and/or cyclosporine? 183
At physiologic albumin:oleate concentrations oleate uptake by isolated hepatocytes, adipocytes and cardiac myocytes is a saturable function of unbound oleate concentrations. Uptake kinetics are consistent with the conventional theory 182
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 181
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 180
Hepatocellular 22Na+ uptake: effect-of-oleate 179
Transferrin metabolism in alcoholic liver disease. 179
Prevention of postoperative recurrence of Crohn's disease: does the type of surgery matter? 178
Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution. 178
The race for mainstream gastrointestinal endoscopy: frontrunners. 177
Postoperative recurrence of Crohn's disease: the beginning of the end? 174
Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? 172
Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase. 171
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet 171
Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione. 171
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. 171
Surgery for Crohn's disease and anti-TNF agents. The changing scenario 170
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 170
Bile acid secretion and pool size during phenobarbital-induced hypercholeresis 169
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy 169
Fibrocytes, Inflammation, and Fibrosis in Crohn's Disease: Another Piece of the Puzzle. 169
Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate 168
Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43 kDa plasma membrane fatty acid binding protein 166
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients 166
Prevention of postoperative recurrence of Crohn's disease by infliximab 166
Hepatic disposition of clinically useful 5-nitrofurans 165
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus 165
Uptake of oleate by isolated rat adipocytes is mediated by a 40 kDa plasma membrane fatty acid binding protein closely related to that in liver and gut 164
Ustekinumab as induction and maintenance therapy for Crohn's disease 164
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease 164
The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver 163
Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab 162
Diagnosis and assessment of Crohn's disease: the present and the future 161
Low dose infliximab for prevention of postoperative recurrence of crohn's disease: Long term follow-up and impact of infliximab trough levels and antibodies to infliximab 161
The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease. 160
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. 160
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 159
Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort 159
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related 159
MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum 159
Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration 158
Mechanistic aspects of hepatic bilirubin uptake 157
Medical prevention of postoperative recurrence of Crohn’s Disease: The state of the art 155
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. 155
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease 155
Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin 154
Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes 154
Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey 154
Transmembrane TNF-α density, but not soluble TNF-α level, is associated with primary response to infliximab in inflammatory bowel disease 152
Esophageal ulceration due to alendronate 149
Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females 149
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 148
Organic anion-transporting polypeptides: expression cloning and functional tests 148
Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science 148
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 147
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents 146
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? 145
Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease 145
Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis? 145
Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? 144
235) La terapia con Infliximab più Metotrexate a basse dosi nella prevenzione delle recidive post-chirurgiche del Morbo diCrohn 143
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study 143
Heart-touching Chilaiditi's syndrome 143
Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut 143
Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? 143
The hepatocellular uptake of free fatty acids is selectively preserved during starvation 142
Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing. 142
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. 141
Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale 139
Characterization of prelymphomatous stages of lymphoproliferation in Sjögren’s syndrome. 138
Utility of fecal markers to diagnose and monitor inflammatory bowel diseases 135
Gastric B-cell clonal expansion and hepatitis C virus infection: a study in patients with Sjögren’s syndrome. 134
Helicobacter pylori infection and autoimmune processes: an emerging field of study. 134
Continuous monitoring of the biliary excretion of a pulse of labeled compounds 133
Familial hyperbilirubinaemia syndromes: kinetic approaches 132
Quantitation of plasma membrane fatty acid binding protein by enzyme dilution and monoclonal antibody based immunoassay 129
Small Bowel Inflammation in Crohn's Disease and Other Conditions 128
The hepatocellular uptake of bilirubin: current concepts and controversies. 127
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: Kinetic evidence for a high affinity/low capacity sinusoidal membrane system 125
Clinically Significant Small Bowel Crohn's Disease Might Only be Detected by Capsule Endoscopy 124
From albumin to the cytoplasm: the hepatic uptake of organic anions 121
Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease 120
Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome 118
Management of post-operative Crohn’s disease in 2017: where do we go from here? 118
Detailed analysis of total colectomy on health-related quality of life in adult patients with ulcerative colitis 118
Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease 117
Gastric lymphoid follicles: prevalence in patients with dyspepsia and with autoimmune diseases and relationship with Helicobacter pylori infection. Gastroenterology 115
MR of small bowel in patients with Crohn’s disease: Evaluation of inflammatory activity using standard and cine-MR sequences. 115
Risk of combining immunosuppressive and biological treatments in inflammatory bowel disease 113
Totale 16.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022957 0 0 0 85 35 57 73 62 12 201 216 216
2022/20231.193 165 79 14 136 116 368 10 69 163 13 20 40
2023/2024276 51 29 12 2 50 50 4 21 38 2 7 10
2024/20252.685 29 171 81 38 211 183 199 192 289 242 339 711
2025/20264.082 267 529 382 375 672 320 474 132 222 366 228 115
2026/20271.397 124 451 347 475 0 0 0 0 0 0 0 0
Totale 19.920